GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biodexa Pharmaceuticals Plc (NAS:BDRX) » Definitions » Total Debt per Share

Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Total Debt per Share : $0.20 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Biodexa Pharmaceuticals Total Debt per Share?

$0.20 (As of Dec. 2023)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Biodexa Pharmaceuticals's Total Debt Per Share for the quarter that ended in Dec. 2023 was $0.20.


Biodexa Pharmaceuticals Total Debt per Share Historical Data

The historical data trend for Biodexa Pharmaceuticals's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biodexa Pharmaceuticals Total Debt per Share Chart

Biodexa Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,720.48 44.42 82.70 56.13 0.20

Biodexa Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.70 71.32 56.13 0.99 0.20

Biodexa Pharmaceuticals Total Debt per Share Calculation

Biodexa Pharmaceuticals's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Biodexa Pharmaceuticals's Total Debt Per Share for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biodexa Pharmaceuticals Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Biodexa Pharmaceuticals's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ
Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.